Benjamin Edwards Inc’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $591K | Buy |
63,034
+1,126
| +2% | +$10.6K | 0.01% | 799 |
|
2025
Q1 | $440K | Sell |
61,908
-2,157
| -3% | -$15.3K | 0.01% | 826 |
|
2024
Q4 | $747K | Buy |
64,065
+6,396
| +11% | +$74.6K | 0.01% | 706 |
|
2024
Q3 | $1.18M | Buy |
57,669
+57,253
| +13,763% | +$1.18M | 0.02% | 551 |
|
2024
Q2 | $9K | Sell |
416
-146
| -26% | -$3.16K | ﹤0.01% | 624 |
|
2024
Q1 | $15K | Buy |
562
+35
| +7% | +$934 | ﹤0.01% | 605 |
|
2023
Q4 | $16K | Sell |
527
-317
| -38% | -$9.62K | ﹤0.01% | 555 |
|
2023
Q3 | $27K | Buy |
844
+78
| +10% | +$2.5K | 0.01% | 517 |
|
2023
Q2 | $31K | Buy |
766
+18
| +2% | +$728 | 0.01% | 507 |
|
2023
Q1 | $28K | Buy |
748
+38
| +5% | +$1.42K | 0.01% | 512 |
|
2022
Q4 | $25K | Buy |
710
+141
| +25% | +$4.97K | 0.01% | 482 |
|
2022
Q3 | $32K | Sell |
569
-44
| -7% | -$2.48K | 0.01% | 454 |
|
2022
Q2 | $32K | Buy |
613
+6
| +1% | +$313 | 0.01% | 471 |
|
2022
Q1 | $44K | Sell |
607
-81
| -12% | -$5.87K | 0.01% | 467 |
|
2021
Q4 | $81K | Buy |
688
+36
| +6% | +$4.24K | 0.03% | 372 |
|
2021
Q3 | $87K | Sell |
652
-198
| -23% | -$26.4K | 0.05% | 246 |
|
2021
Q2 | $138K | Sell |
850
-443
| -34% | -$71.9K | 0.09% | 188 |
|
2021
Q1 | $104K | Sell |
1,293
-8
| -0.6% | -$643 | 0.08% | 198 |
|
2020
Q4 | $71K | Sell |
1,301
-593
| -31% | -$32.4K | 0.06% | 216 |
|
2020
Q3 | $38K | Buy |
1,894
+77
| +4% | +$1.55K | 0.03% | 242 |
|
2020
Q2 | $38K | Hold |
1,817
| – | – | 0.03% | 223 |
|
2020
Q1 | $22K | Sell |
1,817
-61
| -3% | -$739 | 0.02% | 234 |
|
2019
Q4 | $28K | Buy |
1,878
+223
| +13% | +$3.33K | 0.06% | 150 |
|
2019
Q3 | $22K | Sell |
1,655
-36
| -2% | -$479 | 0.05% | 162 |
|
2019
Q2 | $28K | Buy |
1,691
+640
| +61% | +$10.6K | 0.07% | 145 |
|
2019
Q1 | $18K | Buy |
+1,051
| New | +$18K | 0.09% | 169 |
|